According to the Financial Times, Johnson & Johnson (JNJ.N) is seeking to acquire eye disease biotechnology company Ollin Biosciences for up to $3.4 billion.

2026-11-16

According to the Financial Times, Johnson & Johnson (JNJ.N) is seeking to acquire eye disease biotechnology company Ollin Biosciences for up to $3.4 billion.